Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2514 of 5804
-
Herbal supplement ashwagandha tested for Women's sexual wellness
Symptom relief CompletedSexual health is a key part of a woman's overall physical, emotional, and mental well-being-even in the absence of any medical or psychological problems. It includes aspects such as sexual desire, arousal, satisfaction, and confidence in intimate relationships. Everyday factors l…
Phase: NA • Sponsor: SF Research Institute, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Gut health hack: prebiotic may ease daily stress
Symptom relief OngoingThe levels of stress that we experience as a population are continuing to rise due to financial, social and work pressures, particularly in mid-life where additional factors such as family and career often compound these issues. When we experience high levels of stress for prolon…
Phase: NA • Sponsor: University of Reading • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Music may soothe children in the emergency room
Symptom relief CompletedChildren presenting to the emergency department frequently experience anxiety and may undergo various painful procedures. While sedative agents are administered to these patients, they do not consistently provide adequate relief to keep the child calm and cooperative during the p…
Phase: PHASE3 • Sponsor: Tehran University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Could a custom tumor map guide better ovarian cancer care?
Knowledge-focused Recruiting nowThe long-term goal of this research project is to demonstrate whether HRD negative (HPDneg) patients benefit when additional multi-modal biological tumor information is incorporated into the molecular tumor board (mTB) treatment recommendation process.
Phase: NA • Sponsor: Swiss GO Trial Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI vs. doctors: can computers speed up fracture diagnosis?
Diagnosis Recruiting nowBrief Summary The purpose of this study is to determine if artificial intelligence (AI) can assist doctors in detecting broken bones, effusions, dislocations and bone lesions more quickly and accurately in an emergency room setting. The study will also evaluate whether AI can sav…
Phase: NA • Sponsor: Salzburger Landeskliniken • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Acupuncture may restore periods lost to chemo in young cancer survivors
Symptom relief Recruiting nowThe purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researche…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Online program aims to curb childhood obesity in Low-Income families
Prevention Recruiting nowThis study will evaluate the effects of two different approaches to support healthy family mealtime, sleep, and screentime routines: A parent leader-guided online program that promotes parent and child self-regulation as a means to improve healthy family routines versus an asynch…
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
New study tracks pain changes in gender minority adults on hormone therapy
Knowledge-focused Recruiting nowTRANSPIRE is an observational study of \~200 individuals who (1) will be initiating gender-affirming hormone therapy (GHT) or (2) are gender minority individuals who do not use GHT. The primary outcome will be to identify how the presence of chronic pain changes overtime with GHT…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New online training aims to ease mental health struggles of doctors and nurses
Symptom relief CompletedThis randomized controlled trial (RCT) aims to evaluate the effectiveness of an online guided self-help intervention developed based on Problem Solving Therapy (PST) and Acceptance and Commitment Therapy (ACT), which are both transdiagnostic low-intensity interventions recommende…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Vitamin D3 and microneedling: a new hope for alopecia areata?
Disease control OngoingAlopecia areata is a common condition that causes sudden, patchy hair loss on the scalp and other body sites. It is believed to occur when the body's immune system mistakenly attacks the hair follicles, leading to hair loss that can range from small patches to more widespread inv…
Phase: NA • Sponsor: Services Institute of Medical Sciences, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a diabetes combo drug melt liver fat better than insulin alone?
Disease control OngoingThis is a single-center, randomized, open-label, controlled clinical trial to compare the effects of a fixed-ratio combination of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) versus insulin glargine 100 U/mL (iGlar) on liver fat content in patients with Type 2 Diabetes…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Shock and crunch: new combo therapy aims to restore balance after stroke
Symptom relief ENROLLING_BY_INVITATIONTo evaluate the effects of the combining transcranial direct current stimulation with core stability exercises on trunk performance in poststroke hemiparetic patients, the secondary outcome is to evaluate the balance and the functional performance of the participants.
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New drug shows promise for bipolar depression in early trial
Symptom relief OngoingThe goal of this clinical trial is to learn if ABX-002 added to participants' existing treatment(s) can improve clinical symptoms of depression and to learn about potential effects on brain chemistry that may correlate with antidepressive effects. This is a single treatment arm,…
Phase: PHASE2 • Sponsor: Autobahn Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Probiotic pill may ward off winter colds, study finds
Prevention CompletedThe goal of this study is to evaluate the efficacy of the LC-Plasma in preventing upper respiratory tract infections (URTIs) in healthy volunteers. Researchers will compare LC-Plasma to placebo to see if LC-Plasma prevents URTIs. Participants will take a tablet containing LC-Plas…
Phase: PHASE3 • Sponsor: RDC Clinical Pty Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
New drug dotinurad takes on febuxostat in battle for heart health
Disease control Recruiting nowThe effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.
Phase: PHASE4 • Sponsor: Saga University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Feeding tube breakthrough: enzyme device could ease digestion for pancreatitis patients
Disease control Recruiting nowThis research aims to improve the management of exocrine pancreatic insufficiency (EPI), a condition that can develop after pancreatitis, a painful inflammation of the pancreas. EPI occurs when the pancreas does not produce enough enzymes to help the body properly digest food. Wh…
Phase: PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New Cell-Based therapy trial aims to tame rare nerve disease
Disease control Recruiting nowThis is a single-center, randomized, open-label, placebo-controlled, dose-escalation trial. The objective of this research is to evaluate the safety, tolerability, and efficacy of intrathecal administration of human-induced neural stem cell-derived extracellular vesicles (NouvSom…
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Light therapy device tested for arthritis pain relief
Symptom relief Recruiting nowStudy Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can alleviate chronic severe pain. Study Design This is a randomized, double-blinded, placebo-controlled intervention clin…
Phase: NA • Sponsor: First Institute of All Medicines • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New app aims to help cancer patients kick the habit
Disease control OngoingDespite the deleterious impact of smoking upon cancer treatment outcomes, smoking prevalence remains alarmingly high among cancer patients. Thus, reducing smoking by cancer patients is a public health priority, but treatments to date have demonstrated limited efficacy. Mobile hea…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis is an open-label, multi-ascending dose (MAD) phase 1 study, with dose expansion at selected doses, in adult patients with select autoimmune rheumatic diseases including systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). The purpose of the study is to identify p…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC